Brian M. Slomovitz, M.D.
- Chief, Division of Gynecologic Oncology
- Obstetrics & Gynecology
Dr. Slomovitz research involves clinical trial development and implementation for gynecologic malignancies. Specifically, He is using the latest immunotherapy, targeted therapy and other rational therapies to limit deaths due to the diseases he treats. One recent example, He was the first to investigate mTOR inhibition in patients with endometrial cancer. In addition, He has led two NCI trials of sentinel lymph node removal for women with early stage vulvar cancer. These have led to the inclusion of this procedure on NCCN guidelines.